Cell surface markers are proteins expressed on the surface of cells that often conveniently serve as markers of specific cell types. The presence of cell surface markers can also determine if a cell type expresses the specific receptor important for a biological response. The broad range of assay technologies for cell surface marker research that enables analysis of gene expression and regulation, epigenetic modification, genotyping, and signal transduction pathway activation. Many markers for specific cell types are known, however, there are others remaining to be discovered, such as novel T cell subtypes.
The global cell surface markers market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global cell surface markers market segmentation is based on instruments and reagents (flow cytometry, hematology analyzers, reagents and kits), and applications (disease diagnosis and identification, research and drug discovery).
The global cell surface markers market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global cell surface markers market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cell surface markers market and included in this report are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.